The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections

NCT00448942 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5300

Last updated 2007-03-19

No results posted yet for this study

Summary

The purpose of this study was to determine if the use of daily chlorhexidine bathing would decrease the incidence of MRSA and VRE colonization and healthcare associated Bloodstream Infections (BSI) among Intensive Care Unit (ICU) patients.

Conditions

  • Nosocomial Bacteremia
  • Nosocomial Fungemia
  • MRSA Colonization
  • MRSA Infection
  • VRE Colonization
  • VRE Infection

Interventions

BEHAVIORAL

Daily bathing with Chlorhexidine based product

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    collaborator OTHER
  • Washington University School of Medicine

    collaborator OTHER
  • Johns Hopkins University

    collaborator OTHER
  • University of Tennessee

    collaborator OTHER
  • Centers for Disease Control and Prevention

    collaborator FED
  • Hunter Holmes Mcguire Veteran Affairs Medical Center

    lead FED

Principal Investigators

  • Edward W Wong, MD · Hunter Holmes Mcguire Veteran Affairs Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Completion
2006-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00448942 on ClinicalTrials.gov